Maternal and umbilical cord serum zidovudine levels in human immunodeficiency virus infection

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 38, Issue 3, 1998, Pages 288-292

  Phuapradit, Winit ^a,b   Sirinavin, Sayomporn ^a,b   Taneepanichskul, Surasak ^a,b   Chaovavanich, Achara ^a,c   Wiratchai, Amornpun ^a,c   Sunthornkachit, Rujanee ^a,c   Puchaiwatanon, Orawan ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c Bamrasnaradura Hospital   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GLUCURONIDE; ZIDOVUDINE;

ADULT; ARTICLE; CORRELATION FUNCTION; DELIVERY; DRUG BLOOD LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MATERNAL BLOOD; ORAL DRUG ADMINISTRATION; PREGNANCY; PRIORITY JOURNAL; THAILAND; UMBILICAL CORD BLOOD;

EID: 0031669614     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.1998.tb03068.x     Document Type: Article

References (16)

1. Conner EN, Sperling RS, Gelber R et al. Reduction of maternal infant transmission of human immunodeficiency type 1 with zidovudine treatment. N Engl J Med 1994; 331: 1173-1194.
2. Sperling RS, Shapiro DE, Coombs RW et al.Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1996; 335: 1621-1629.
3. Taneepanichskul S. Prevalence of HIV-1 positive mothers in Thailand 1990-1993. J Obstet Gynaecol 1995; 21 (Suppl): 207.
4. O'Sullivan MJ, Boyer PH, Scott GB et al. The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Am J Obstet Gynecol 1993; 168: 1510-1516.
5. Boucher FD, Modlin JF, Weller S et al. Phase I evaluation of zidovudine administered to infants exposed at birth to human immunodeficiency virus. J Pediatr 1993; 122: 137-144.
6. Good S, Reynolds P, De Miranda P. Simultaneous quantification of zidovudine and its glucuronide in serum by high performance liquid chromatography. J Chromatogr 1989; 431: 123-133.
7. Boyer PJ, Dillon M, Navaie M et al. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA 1994; 271: 1925-1930.
8. Frenkel LM, Wagner LE, Demeter LM et al. Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1. Clin Infect Dis 1995; 20: 1321-1326.
9. Matheson PB, Abrams EJ, Thomas PA et al and the New York City Perinatal HIV Transmission Collaborative Study Group Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type 1. J Infect Dis 1995; 172: 353-358.
10. Brossard Y, Aubin JT, Mandelbrot L et al. Frequency of early in utero HIV-1 infection: A blind DNA polymerase chain reaction study on 100 fetal thymuses. AIDS 1995; 9: 359-366.
11. Phuapradit W, Chaturachinda K, Taneepanichskul S, Khupulsup K. Raksakait K, Kunakorn M. Vertical transmission of HIV-1 in mid-trimester gestation. Aust NZ J Obstet Gynaecol 1993; 35: 427-430.
12. Ho-Hsiung L, Lia-Horng K, Hong-Yuan H, Masashi M, Kazuyuki H, Ding-Shinn C. Least microtransfusion from mother to fetus in elective cesarean delivery. Obstet Gynecol 1996; 87: 244-248.
13. Chavanet P, Diquet B, Waldner A, Pertier H. Perinatal pharmacokinetics of zidovudine. Correspondence. N Engl J Med 1989; 30; 1548.
14. MacNab KA, Gill MJ, Sutherland LR. Erratic zidovudine bioavailability in HIV seropositive patients. J Antimicro Chemo 1993; 31: 421-428.
15. Furman PA, Fyfe JS, St Clair MH et al. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci USA 1986; 83: 8333-8337.
16. Sommadossi JP. Nucleoside analogs: similarities and differences. Clin Inf Dis 1993; 16 (Suppl I): 7-15.